Eli Lilly’s $4 Billion Vaccine Bet
In this week’s edition of InnovationRx, we look at the spreading Ebola epidemic, the Midas list health investors, Lilly’s trio of vaccine deals, and more.
ByAmy Feldman,
Senior Editor
Inside Incyte’s $120 Million AI For Drug Development Deal
In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 billion valuation, and more.
ByAmy Feldman,
Senior Editor
Public Health Officials Believe The Hantavirus Outbreak Is Under Control
In this week’s edition of InnovationRx, we look at the latest on the hantavirus outbreak, using quantum physics for metabolic MRIs, how AI can help fill prescriptions and more.
ByAmy Feldman,
Senior Editor
First U.S. Patients Treated With Microrobotic Surgery For Alzheimer’s
Indian billionaire Dilip Shanghvi’s plans to expand his healthcare empire in the U.S., the hantavirus outbreak on a cruise ship, and more
ByAlex Knapp,
Senior Editor
The Trump Administration Is Shifting Federal Policy On Cannabis And Psychedelics
In this week’s edition of InnovationRx, we look at a new drug cost partnership, a brain implant deal, and more.
ByAlex Knapp,
Senior Editor
Using AI To Personalize Healthcare–Without Losing Patient Trust
In this week’s edition of InnovationRx, we look at the opportunities and challenges of using AI to personalize healthcare and speed up clinical trials, the future of genetic medicine, another big Lilly acquisition, and more.
ByAlex Knapp,
Senior Editor
This Pill May Help Pancreatic Cancer Patients Live Longer
In this week’s edition of InnovationRx, we look at the top self-made healthcare entrepreneurs, the latest 30 Under 30 Science & Healthcare list, and more.
ByAmy Feldman,
Senior Editor
Trump’s New Pharmaceutical Tariffs Will Hit Small Drugmakers Hardest
In this week’s edition of InnovationRx, we look at the first robotic cataract surgeries in humans, the underbelly of marketing compounded GLP-1s, and more.
ByAmy Feldman,
Senior Editor
Why The Federal Government Wants Agentic AI To Treat Heart Failure
In this week’s edition of InnovationRx, we look the billionaire dentist, Wegovy by subscription, Kailera’s planned IPO, and more.
ByAmy Feldman,
Senior Editor
The Iran War Could Make Your Next MRI More Expensive
In this week’s edition of InnovationRx, we look at a serial entrepreneur’s effort to build an FDA-approved AI doctor, Pfizer’s lyme disease vaccine, and more.
ByAlex Knapp,
Senior Editor